Projects
AGREE II Project (AGREE Next Steps):
Project Overview for Posting to the AGREE Research Trust (ART)
AGREE Next Steps: Continuous Quality Improvement in the Evaluation of Clinical Practice Guidelines.
Since the completion of its initial development and refinement in 2003, the Appraisal of Guidelines Research and Evaluation (AGREE) Instrument has advanced the science of clinical practice guideline (CPG) appraisal and is becoming the international gold standard for CPG evaluation and development. The AGREE Instrument is endorsed by the World Health Organization and as an example, it is used by the Guidelines International Network as its CPG framework for development and quality, by the Ontario Guidelines Advisory Committee for its CPG endorsement strategy, and by the CPG Action Group of the Canadian Strategy for Cancer Control (CSCC) in its national CPG adaptation project.
A new project is currently underway by the original consortium of international researchers to further refine the AGREE instrument. The overall objective of this project is to facilitate the next iteration of the AGREE instrument by conducting research to improve its psychometric properties, in particular to establish its validity and to test its utility.
The culmination of this research will provide clear recommendations for the second version of the AGREE instrument and will bring greater confidence to the CPG enterprise. The expected project completion date is December 2008.
If you would like more information, please contact the project office at agree@mcmaster.ca .
AGREE Next Steps Research Team:
M. Brouwers (PI) Director, Program in Evidence-based Care, Cancer Care Ontario Canada; Associate Professor, Clinical Epidemiology & Biostatistics, McMaster University, Canada
G. Browman Professor, Oncology; BC Cancer Agency, Vancouver Island Cancer Centre, Canada
J. Burgers Guideline Program Director, Dutch Institute for Healthcare Improvement, Netherlands
F. Cluzeau Lecturer, St. George’s Hospital Medical School, London UK
D. Davis Professor, University of Toronto; Chair, Guidelines Advisory Committee, Ontario Canada
G. Feder Associate Professor, Bart’s & the London Queen Mary’s School of Medicine, UK
B. Fervers Deputy Director, Federation nationale des centres de lutte contre le cancer, Lyons France
I. Graham Associate Professor, Faculty of Health Sciences, University of Ottawa, Canada
J. Grimshaw Director, Clinical Epidemiology Program, Ottawa Health Research Institute, Canada
S. Hanna Associate Professor, Clinical Epidemiology & Biostatistics, McMaster University, Canada
P. Littlejohns Director, Clinical and Public Health, National Institute for Health and Clinical Excellence, UK
G. Ollenschlaeger Director, German Agency for Quality in Medicine, Germany
L. Zitzelsberger Research Associate, Ottawa Health Research Institute, Canada
Project Coordinators: M. Kho and J. Makarski
Project Email: agree@mcmaster.ca
Project funded by: Canadian Institutes of Health Research
REB approved: Research Ethics Board of McMaster University, Faculty of Health Sciences (Ontario, Canada)
Posted: June 2007